1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine | 184302-49-6

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 核苷和核苷酸类似物
• 英文名称: 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine
• 英文别名: FF-10502；4'-Thio-fac；4-amino-1-[(2R,3S,4S,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidin-2-one
• CAS: 184302-49-6
• 化学式: C₉H₁₂FN₃O₃S
• 分子量: 261.277
• InChiKey: NIDPJRZOVFIBQB-PXBUCIJWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.8
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  124
• 氢给体数：
  3
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine 在 sodium nitrate 、 溶剂黄146 作用下， 生成 1-((2R,3S,4S,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl)pyrimidine-2,4(1H,3H)-dione
  参考文献：
  名称：

  KR2023/10349

  摘要：

  公开号：
• 作为产物：
  描述：

  生成 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine
  参考文献：
  名称：

  1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine

  摘要：

  本发明涉及具有优异的抗肿瘤活性的1-(2-脱氧-2-氟-4-硫-β-D-阿拉伯呋喃糖基)胞嘧啶，其化学式为[I]：##STR1##其中R表示氢原子或磷酸残基，以及其制备和使用的方法。

  公开号：

  US06147058A1

文献信息

• [EN] BIOREDUCTIVELY-ACTIVATED PRODRUGS<br/>[FR] PROMÉDICAMENTS ACTIVÉS PAR UNE BIORÉDUCTION
  申请人：ANGIOGENE PHARM LTD

  公开号：WO2006032921A1

  公开（公告）日：2006-03-30

  The present invention relates to a compound of formula (1), or a pharmaceutically acceptable salt thereof, Formula: (1); wherein: R1 is a substituted aryl or heteroaryl group bearing at least one nitro or azido group or is an optionally substituted benzoquinone, optionally substituted naphthoquinone or optionally substituted fused heterocycloquinone; R2 is H, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, aryl or heteroaryl; and R3 is selected such that R3NH2 represents a cytotoxic nucleoside analogue or an ester or phosphate ester prodrug of a cytotoxic nucleoside analogue, with the proviso that if R1 is an aryl group then R2 is not H.

  本发明涉及一种具有如下式（1）的化合物，或其药学上可接受的盐，式中：R1是带有至少一个硝基或偶氮基的取代芳基或杂环芳基，或者是可选择取代的苯醌、可选择取代的萘醌或可选择取代的融合杂环喹啉；R2是H、可选择取代的烷基、可选择取代的烯基、可选择取代的炔基、可选择取代的环烷基、可选择取代的杂环烷基、芳基或杂环芳基；R3被选择为R3NH2，表示细胞毒性核苷类似物或细胞毒性核苷类似物的酯或磷酸酯前药，但如果R1是芳基，则R2不是H。
• THIONUCLEOSIDE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION
  申请人：FUJIFILM Corporation

  公开号：US20170233429A1

  公开（公告）日：2017-08-17

  Disclosed are a compound and a pharmaceutical composition that exhibit an excellent drug efficacy against a tumor, in particular a tumor which has acquired resistance to gemcitabine. Specifically, provided is a thionucleoside derivative represented by General Formula [1] (in the formula, R 1 represents a hydroxyl group which may be protected, a C 1-20 alkoxy group which may be substituted, or the like; R 2 represents a C 1-20 alkoxy group which may be substituted, a C 3-8 cycloalkoxy group which may be substituted, or the like; and R 3 represents a hydrogen atom or the like); or a salt thereof. Further, provided is a pharmaceutical composition containing such a thionucleoside derivative or a salt thereof.

  揭示了一种化合物和药物组合物，对抗抗对吉西他滨产生耐药性的肿瘤表现出优异的药效。具体来说，提供了一种由通用式[1]表示的硫代核苷衍生物 （在公式中，R1代表可能被保护的羟基、可能被取代的C1-20烷氧基等；R2代表可能被取代的C1-20烷氧基、可能被取代的C3-8环烷氧基等；R3代表氢原子等）或其盐。此外，提供了含有这种硫代核苷衍生物或其盐的药物组合物。
• METHOD FOR PRODUCING THIOLANE SKELETON-TYPE GLYCOCONJUGATE, AND THIOLANE SKELETON-TYPE GLYCOCONJUGATE
  申请人：FUJIFILM Corporation

  公开号：US20160355536A1

  公开（公告）日：2016-12-08

  There is provided a production method of a compound represented by the following formula (II) through a step of reacting a compound represented by the following General Formula (I) with a sulfur compound. In General Formulas (I) and (II), R 1 represents a hydrogen atom or an acyl group, R 2 represents a hydrogen atom, a fluorine atom, an acyloxy group, an arylmethyloxy group, an allyloxy group, an arylmethyloxycarbonyloxy group, or an allyloxycarbonyloxy group, R 3 represents a hydrogen atom or an acyloxy group, R 5 represents an alkyl group or an aryl group, and X represents a leaving group. Here, in a case where R 2 is a fluorine atom, an acyloxy group, an arylmethyloxy group, an allyloxy group, an arylmethyloxycarbonyloxy group, or an allyloxycarbonyloxy group, R 3 is an acyloxy group.

  提供了一种通过将通用式（I）表示的化合物与硫化合物反应的步骤来制备通式（II）表示的化合物的生产方法。在通式（I）和（II）中，R1代表氢原子或酰基，R2代表氢原子、氟原子、酰氧基、芳基甲氧基、烯丙氧基、芳基甲氧羰氧基或烯丙氧羰氧基，R3代表氢原子或酰氧基，R5代表烷基或芳基，X代表离去基团。在R2为氟原子、酰氧基、芳基甲氧基、烯丙氧基、芳基甲氧羰氧基或烯丙氧羰氧基的情况下，R3为酰氧基。
• SOLID FORM OF 4'-THIO-2'-FLUORONUCLEOSIDE PHOSPHAMIDE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF
  申请人：SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.

  公开号：US20190241603A1

  公开（公告）日：2019-08-08

  The present invention relates to a solid form of a compound of Formula (I), a method for preparing the solid form, a pharmaceutical composition comprising the solid form, and the use of the solid form in the treatment of a disease involving abnormal cell proliferation or a viral infectious disease.

  本发明涉及化合物Formula (I)的固体形式，制备该固体形式的方法，包含该固体形式的药物组合物，以及在治疗涉及异常细胞增殖或病毒感染疾病中使用该固体形式的用途。
• [EN] DINUCLEOTIDE COMPOUNDS FOR TREATING CANCERS AND MEDICAL USES THEREOF<br/>[FR] COMPOSÉS DINUCLÉOTIDIQUES POUR LE TRAITEMENT DE CANCERS ET LEURS UTILISATIONS MÉDICALES
  申请人：PINOTBIO INC

  公开号：WO2021020879A1

  公开（公告）日：2021-02-04

  The present disclosure provides the dinucleotide compounds which is useful for treating various cancers. The present disclosure also provides a composition comprising the compound or its pharmaceutically acceptable salt. The present disclosure also provides a medical use of the compound, its salt or the composition comprising the compound or its pharmaceutically acceptable salt for treating cancer. The present disclosure also provides a method of treatment of cancer comprising administering the compound, its salt or the composition comprising the compound or its salt to a subject in need of such treatment.

  本公开提供了二核苷酸化合物，用于治疗各种癌症。本公开还提供了包含该化合物或其药用盐的组合物。本公开还提供了该化合物、其盐或包含该化合物或其药用盐的组合物用于治疗癌症的医疗用途。本公开还提供了一种治疗癌症的方法，包括向需要此类治疗的受试者投与该化合物、其盐或包含该化合物或其盐的组合物。